Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Apr 2015

Kautzky Alexander, Baldinger Pia, Souery Daniel, Montgomery Stuart, Mendlewicz Julien, Zohar Joseph, Serretti Alessandro, Lanzenberger Rupert, Kasper Siegfried

Abstract excerpt

For over a decade, the European Group for the Study of Resistant Depression (GSRD) has examined single nucleotide polymorphisms (SNP) and clinical parameters in regard to treatment outcome. However, an interaction based model combining these factors has not been established yet. Regarding the low...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain-Derived Neurotrophic Factor

Share to Calcineurin

Share to Catechol O-Methyltransferase

Share to Pharmacogenetics

Share to Receptor, Serotonin, 5-HT2A

Share to Sialyltransferases

Source

Identifiers

PMID: 25769916
DOI: 10.1016/j.euroneuro.2015.01.001

Genes

BDNF
COMT
TRD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25769916-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.PMID 25769916Read ↗

Role of the Pharmacogenomics in the Treatment-Resistant Depression: A Literature ReviewSemantic proximity Read ↗

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotypingSemantic proximity Read ↗

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.Semantic proximity Read ↗

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.Semantic proximity Read ↗

The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.Semantic proximity Read ↗

Genome-wide association study of treatment resistant depression highlights shared biology with metabolic traitsSemantic proximity Read ↗

Integrating Genetic Variants and Expression Profiles of Pharmacogenes in Treatment- Resistant DepressionSemantic proximity Read ↗

Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohortsSemantic proximity Read ↗

Genomic predictors of response to antidepressants in Major depressive disorder (MDD): A GWAS-Based Study on Indian cohortSemantic proximity Read ↗

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.Semantic proximity Read ↗

Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis.Semantic proximity Read ↗

Genetics of Response to ECT, TMS, Ketamine and Esketamine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.